首页> 中文期刊> 《山东医药》 >经皮脾门静脉核素显像、B超及胃镜对肝硬化 门脉高压诊断价值的对比研究

经皮脾门静脉核素显像、B超及胃镜对肝硬化 门脉高压诊断价值的对比研究

         

摘要

To investigate and evaluate the methods for the dignosis ofcirrhotics with portal hypertension. Spleno-portal vein shape and portosystemic shunt index(PSSI)were determined through portal circulation imaging by using intrasplenic injection of 99m Tc-Phytate.Comparision was also made with gastroscopy and ultrasonography.Results showed that the liver cirrhostics with portal hypertension were separated into four type,namely nonshunt,shunt,with collateral vein and full-extrahepatic shunt type by splenoportoscintigraphy. The PSSI for controls was 0.192±0.068,chronic hepatitis was 0.246±0.057,cirrhosis was 0.541±0.082,cirrhosis Child-pugh A 0.384±0.052,B 0.523±0.07,C 0.680±0.081.If the threshold for cirrhosis was set at PSSI>0.36,the sensitivity was 91.7%,superior to the above other methods.It suggests that splenoportoscintigraphy is capable showing splenoportal circulation shape and helpful in dignosing cirrhosis at its early stage and evaluating prognosis.%为探讨经脾门静脉核素显像、胃镜及B超检查在肝硬化门脉高压诊断中的价值及其相关性,采用99m锝-植酸钠(99mTc-Phytate)经脾细针穿刺给药法对58例肝病与非肝病患者进行了经脾门静脉单光子发射计算机断层(SPECT)显像,以观察及门脉循环情况,计算门体分流指数(PSSI),并与胃镜、B超进行比较。结果显示,经脾门静脉核素显像可将肝硬化门脉高压分为四型,即无分流型、有分流型(包括肝内、外分流)、有侧支循环型、完全肝外分流型。PSSI值非肝病对照组为0.192±0.068,慢性肝病组为0.246±0.057,肝硬化门脉高压组为0.541±0.082。按肝硬化ChildA、B、C分级,三组分别为0.384±0.052、0.523±0.072、0.680±0.081。若以PSSI>0.36为判别阈,肝硬化组总阳性率为91.7%,其诊断价值明显优于B超及胃镜。提示经脾门静脉核素显像既能显示脾门静脉形态及侧支循环,又能测定PSSI,有助于肝硬化的早期诊断、治疗选择及预后判断。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号